Single fraction high-dose-rate brachytherapy as monotherapy for low and intermediate risk prostate cancer: toxicities and early outcomes from a single institutional experience
Justin Barnes, Prashant Gabani, Max Sanders, Anupama Chundury, Michael Altman, Jose Garcia-Ramirez, Harold Li, Jacqueline Zoberi, Brian Baumann, Hiram Gay
January, 2019